Skip to main content
Amit Majithia, MD, Endocrinology, San Diego, CA

Amit Majithia MD

Diabetes, Lipid Metabolism


Physician

Join to View Full Profile
  • 200 W Arbor DrSan Diego, CA 92103

  • Phone+1 800-926-8273

  • Fax+1 888-539-8781

Dr. Majithia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York University School of Medicine
    New York University School of MedicineClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2026
  • GA State Medical License
    GA State Medical License 2018 - 2020
  • MA State Medical License
    MA State Medical License 2009 - 2020
  • AR State Medical License
    AR State Medical License 2018 - 2019
  • MS State Medical License
    MS State Medical License 2018 - 2019
  • SC State Medical License
    SC State Medical License 2018 - 2019
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Grant Support

  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Credentialing metabolic disease genes through human genetics and functional genomicsVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2027
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humansUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
  • Credentialing novel cardiovascular disease genes in women by sex-specific genomic investigation of insulin resistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
  • Credentialing novel cardiovascular disease genes in women by sex-specific genomic investigation of insulin resistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
  • Credentialing novel cardiovascular disease genes in women by sex-specific genomic investigation of insulin resistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
  • Credentialing novel cardiovascular disease genes in women by sex-specific genomic investigation of insulin resistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2025
  • Molecular Biological Approaches to EndocrinologyUNIVERSITY OF CALIFORNIA, SAN DIEGO1986–2025
  • Combining experiments of man and nature to target human insulin resistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: